Jpmorgan Chase & CO Utah Medical Products Inc Transaction History

Jpmorgan Chase & CO

  • $1.27 Trillion
  • Q1 2025

A detailed history of Jpmorgan Chase & CO transactions in Utah Medical Products Inc stock. As of the latest transaction made, Jpmorgan Chase & CO holds 72,329 shares of UTMD stock, worth $4.16 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
72,329
Previous 79,703 9.25%
Holding current value
$4.16 Million
Previous $4.9 Million 17.27%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 12, 2025
SELL
$56.04 - $64.17 $413,238 - $473,189
-7,374 Reduced 9.25%
72,329 $4.05 Million
Q4 2024

Feb 12, 2025
BUY
$60.9 - $68.52 $626,782 - $705,207
10,292 Added 14.83%
79,703 $4.9 Million
Q3 2024

Dec 26, 2024
BUY
$65.79 - $75.08 $437,174 - $498,906
6,645 Added 10.59%
69,411 $4.64 Million
Q3 2024

Nov 08, 2024
BUY
$65.79 - $75.08 $437,174 - $498,906
6,645 Added 10.59%
69,411 $4.64 Million
Q2 2024

Dec 26, 2024
SELL
$65.92 - $70.99 $438,038 - $471,728
-6,645 Reduced 9.57%
62,766 $4.19 Million
Q2 2024

Aug 12, 2024
SELL
$65.92 - $70.99 $645,093 - $694,708
-9,786 Reduced 13.49%
62,766 $4.19 Million
Q1 2024

Dec 26, 2024
BUY
$68.14 - $84.23 $214,027 - $264,566
3,141 Added 4.53%
72,552 $5.16 Million
Q1 2024

May 10, 2024
BUY
$68.14 - $84.23 $608,081 - $751,668
8,924 Added 14.03%
72,552 $5.16 Million
Q4 2023

Dec 26, 2024
SELL
$77.07 - $87.05 $445,695 - $503,410
-5,783 Reduced 8.33%
63,628 $5.36 Million
Q4 2023

Feb 12, 2024
BUY
$77.07 - $87.05 $413,249 - $466,762
5,362 Added 9.2%
63,628 $5.36 Million
Q3 2023

Nov 14, 2023
SELL
$83.86 - $99.16 $22,474 - $26,574
-268 Reduced 0.46%
58,266 $5.01 Million
Q2 2023

Aug 11, 2023
SELL
$87.76 - $99.95 $2.36 Million - $2.69 Million
-26,934 Reduced 31.51%
58,534 $5.46 Million
Q1 2023

May 18, 2023
BUY
$87.14 - $100.3 $229,962 - $264,691
2,639 Added 3.19%
85,468 $8.1 Million
Q1 2023

May 11, 2023
SELL
$87.14 - $100.3 $33,461 - $38,515
-384 Reduced 0.46%
82,829 $7.85 Million
Q4 2022

Feb 13, 2023
SELL
$82.45 - $101.88 $759,694 - $938,722
-9,214 Reduced 9.97%
83,213 $8.37 Million
Q3 2022

Nov 14, 2022
SELL
$80.73 - $95.26 $919,272 - $1.08 Million
-11,387 Reduced 10.97%
92,427 $7.89 Million
Q2 2022

Aug 11, 2022
BUY
$81.49 - $90.28 $166,647 - $184,622
2,045 Added 2.01%
103,814 $8.92 Million
Q1 2022

May 11, 2022
BUY
$86.04 - $99.89 $1.26 Million - $1.47 Million
14,693 Added 16.87%
101,769 $9.15 Million
Q4 2021

Feb 10, 2022
SELL
$88.84 - $124.71 $585,011 - $821,215
-6,585 Reduced 7.03%
87,076 $8.71 Million
Q3 2021

Nov 12, 2021
BUY
$84.89 - $97.16 $7.95 Million - $9.1 Million
93,661 New
93,661 $8.7 Million

Others Institutions Holding UTMD

# of Institutions
109
Shares Held
2.2M
Call Options Held
0
Put Options Held
0
View Full List

About UTAH MEDICAL PRODUCTS INC

UTMD Quotes by TradingView
  • Ticker UTMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 3,625,200
  • Market Cap $209M
  • Description
  • Utah Medical Products, Inc. develops, manufactures, and distributes medical devices for the healthcare industry. The company offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems. It also provides GESCO u...
More about UTMD
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email